Clinical measures in transthyretin familial amyloid polyneuropathy

被引：53
|
作者：
Coelho, Teresa [1 ]
Vinik, Aaron [2 ]
Vinik, Etta J. [2 ]
Tripp, Tara [3 ]
Packman, Jeff [4 ]
Grogan, Donna R. [4 ]
机构：
[1] Hosp Santo Antonio, Ctr Hosp Porto, P-4099001 Oporto, Portugal
[2] Eastern Virginia Med Sch, Strelitz Diabet Ctr, Norfolk, VA 23501 USA
[3] DM Stat Inc, Malden, MA USA
[4] FoldRx Pharmaceut Inc, Cambridge, MA USA
来源：
MUSCLE & NERVE | 2017年 / 55卷 / 03期
关键词：
amyloidosis; modified body mass index; nerve fiber function; Neuropathy Impairment Score; Norfolk Quality of Life; ROCHESTER DIABETIC-NEUROPATHY; RETINOL-BINDING-PROTEIN; LIVER-TRANSPLANTATION; FOLLOW-UP; PERIPHERAL NEUROPATHY; END-POINTS; TAFAMIDIS; SURVIVAL; TRIAL; DYSFUNCTION;
D O I：
10.1002/mus.25257
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IntroductionThis observational, cross-sectional, single-center study aimed to identify instruments capable of measuring disease progression in transthyretin familial amyloid polyneuropathy (TTR-FAP). MethodsThe relationship between disease stage and Neuropathy Impairment Score-Lower Limbs (NIS-LL) and Norfolk Quality of Life-Diabetic Neuropathy (Norfolk QOL-DN) total score was assessed in 61 (stages 1-3) patients with TTR-FAP (V30M variant) and 16 healthy controls. Composite measures of large- and small-nerve fiber function, and modified body mass index (mBMI) were also assessed. ResultsOrdinal-based NIS-LL and Norfolk QOL-DN scores discriminated between disease stages (P<0.0001 for NIS-LL and Norfolk QOL-DN). Longer disease duration correlated with worse NIS-LL and Norfolk QOL-DN. Karnofsky performance score declined progressively by disease stage. Composite measures of nerve fiber function differentiated stage 1 from stage 2 disease. The mBMI declined with advancing disease. ConclusionsNIS-LL, Norfolk QOL-DN score, composite endpoints of nerve fiber function, and mBMI are valid, reliable measures of TTR-FAP severity. Muscle Nerve55: 323-332, 2017
引用
收藏
页码：323 / 332
页数：10
相关论文
共 50 条
  • [41] Tafamidis for the treatment of transthyretin-associated familial amyloid polyneuropathy
    Schmidt, Hartmut H-J
    EXPERT OPINION ON ORPHAN DRUGS, 2013, 1 (10): : 837 - 845
  • [42] AMBULATORY MEDICINES COST WITH TRANSTHYRETIN FAMILIAL AMYLOID POLYNEUROPATHY IN PORTUGAL
    Ines, M.
    Coelho, T.
    Conceicao, I
    Mourao, A.
    Carvalho, M.
    Costa, J.
    VALUE IN HEALTH, 2015, 18 (07) : A667 - A667
  • [43] Current and Future Treatment Approaches in Transthyretin Familial Amyloid Polyneuropathy
    Philippe Kerschen
    Violaine Planté-Bordeneuve
    Current Treatment Options in Neurology, 2016, 18
  • [44] Secondary Glaucoma in transthyretin (TTR)-related Familial Amyloid Polyneuropathy
    Rousseau, Antoine
    Barreau, Emmanuel
    Kaswin, Godefroy
    Mgarrech, Mohamed
    Theaudin, Marie
    Cauquil, Cecile
    Adams, David
    Labetoulle, Marc
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [45] TAFAMIDIS FOR TRANSTHYRETIN FAMILIAL AMYLOID POLYNEUROPATHY: A RANDOMIZED, CONTROLLED TRIAL
    Merkies, Ingemar S. J.
    NEUROLOGY, 2013, 80 (15) : 1444 - 1445
  • [46] Transthyretin Val 107 in a Japanese patient with familial amyloid polyneuropathy
    Nanri, K
    Utsumi, H
    Yamada, M
    Takata, Y
    Matsumura, A
    Kougo, K
    Sekine, S
    Ogawa, D
    Toyoda, M
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 198 (1-2) : 93 - 96
  • [47] Cognitive impairment in transthyretin-related familial amyloid polyneuropathy
    Alves, P. N.
    Castro, V.
    Franco, A.
    Martins, I. P.
    Conceicao, I.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 142 - 143
  • [48] Tafamidis for transthyretin familial amyloid polyneuropathy A randomized, controlled trial
    Coelho, Teresa
    Maia, Luis F.
    da Silva, Ana Martins
    Cruz, Marcia Waddington
    Plante-Bordeneuve, Violaine
    Lozeron, Pierre
    Suhr, Ole B.
    Campistol, Josep M.
    Conceicao, Isabel Maria
    Schmidt, Hartmut H. -J.
    Trigo, Pedro
    Kelly, Jeffery W.
    Labaudinie, Richard
    Chan, Jason
    Packman, Jeff
    Wilson, Amy
    Grogan, Donna R.
    NEUROLOGY, 2012, 79 (08) : 785 - 792
  • [49] Relationship between objective measures of neuropathy and quality of life in stages of severity of transthyretin familial amyloid polyneuropathy
    Coelho, T.
    Merkies, I.
    Vinik, A.
    Vinik, E. J.
    Chan, J.
    Packman, J.
    Grogan, D. R.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2010, 17 : 138 - 139
  • [50] Clinical variant of familial amyloid polyneuropathy
    Quan, D
    Cohen, JA
    MUSCLE & NERVE, 2002, 26 (03) : 417 - 420
12345